Table 1.
Clinical characteristics
| Arm A (IM) | Arm B (ID/SQ) | Total | |
|---|---|---|---|
| N | 13 | 12 | 25 |
| Gender N male (%) | 5 (38 %) | 7 (58 %) | 12 (48 %) |
| Age: mean (range) | 56 (39–82) | 54 (40–69) | 55 (39–82) |
| Race/ethnicity | |||
| White, non-Hispanic | 13 | 11 | 24 |
| Native American | 0 | 1 | 1 |
| Stage at registration | |||
| IIIB | 3 | 5 | 8 |
| IIIC | 5 | 3 | 8 |
| IV | 5 | 4 | 9 |
| ECOG performance status | |||
| 0 | 12 (92 %) | 10 (83 %) | 22 (88 %) |
| 1 | 1 (8 %) | 2 (17 %) | 3 (12 %) |
| Reason off-treatment | |||
| Treatment completed | 13 | 11 | 24 |
| Disease progression | 0 | 1 | 1 |